
How to Decide Who Should Get a COVID-19 Vaccine First
Medical ethicist Ezekiel Emanuel discusses a framework for equitably allocating COVID-19 vaccines based on preventing premature deaths and mitigating long-term economic impacts

How to Decide Who Should Get a COVID-19 Vaccine First
Medical ethicist Ezekiel Emanuel discusses a framework for equitably allocating COVID-19 vaccines based on preventing premature deaths and mitigating long-term economic impacts

In the Fight against Infectious Disease, Social Changes Are the New Medicine
Vaccines and drugs drove a century of progress, but today’s contagions thrive on inequality


Evidence for Convalescent Plasma Coronavirus Treatment Lags behind Excitement
Despite calls for more rigorous clinical trials, the Food and Drug Administration has granted an emergency authorization for the therapy

Thousands Volunteer for COVID-19 Vaccine Study
Late-stage clinical trials of the first two coronavirus vaccine candidates in the U.S. plan to recruit 60,000 Americans

Fluoridated Water Criticized as Socialized Medicine
Originally published in February 1955

Pill Takes the Bite Out of Viper Venom
A preexisting drug could buy time for snakebite treatment

Fauci Optimistic About COVID-19 Vaccines, Though Immunity Unknowns Complicate Development
Teams are starting to test vaccines using messenger RNA or chimpanzee cold viruses to inoculate humans. Will their benefits last?

Concerns about Waning COVID-19 Immunity Are Likely Overblown
The decline seen in some studies is normal, experts say. But scientists must wait to see whether infection confers long-term protection

Vaccine Trials Should Reflect America’s Diversity
Racial minorities and those with underlying health conditions may be at a greater risk from coronavirus infection, but have historically been less likely to be included in clinical trials

Experimental Blood Test Detects Cancer up to Four Years before Symptoms Appear
The assay looks for stomach, esophageal, colorectal, lung and liver malignancies

The Coronavirus Outbreak Could Make it Quicker and Easier to Trial Drugs
Remote clinical trials and other changes could permanently alter pharmaceutical development

Viral Learning Curve
Drug manufacturers are racing to create a protective measure against coronavirus without destroying the patient’s immune system